Correlation Between Dianthus Therapeutics and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Editas Medicine, you can compare the effects of market volatilities on Dianthus Therapeutics and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Editas Medicine.
Diversification Opportunities for Dianthus Therapeutics and Editas Medicine
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dianthus and Editas is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Editas Medicine go up and down completely randomly.
Pair Corralation between Dianthus Therapeutics and Editas Medicine
Given the investment horizon of 90 days Dianthus Therapeutics is expected to generate 1.04 times more return on investment than Editas Medicine. However, Dianthus Therapeutics is 1.04 times more volatile than Editas Medicine. It trades about 0.05 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.06 per unit of risk. If you would invest 1,216 in Dianthus Therapeutics on November 1, 2024 and sell it today you would earn a total of 961.00 from holding Dianthus Therapeutics or generate 79.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dianthus Therapeutics vs. Editas Medicine
Performance |
| Timeline |
| Dianthus Therapeutics |
| Editas Medicine |
Dianthus Therapeutics and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dianthus Therapeutics and Editas Medicine
The main advantage of trading using opposite Dianthus Therapeutics and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Dianthus Therapeutics vs. High Performance Beverages | Dianthus Therapeutics vs. Oatly Group AB | Dianthus Therapeutics vs. Ambev SA ADR | Dianthus Therapeutics vs. Canlan Ice Sports |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |